http://jcps.bjmu.edu.cn

Journal of Chinese Pharmaceutical Sciences ›› 2017, Vol. 26 ›› Issue (7): 534-544.DOI: 10.5246/jcps.2017.07.060

• Drug administration and clinical pharmacy column • Previous Articles    

A general introduction to the development of Good Laboratory Practice in China

Jing Zhang1,2, Xiaoyu Fan1, Hongtao Jin1*, Xingchao Geng3*   

  1. 1. Institute of Medica, Chinese Academy of Medical Sciences & Pecking Union Medical College, Beijing 100050, China
    2. Development Center for Medical Science and Technology, National Health and Family Planning Commission of the People’s Republic of China, Beijing 100050, China
    3. National Center for Safety Evaluation of Drugs, National Institute for Food and Drug Control, Beijing 100176, China
  • Received:2017-03-20 Revised:2017-05-18 Online:2017-07-28 Published:2017-06-05
  • Contact: Tel.: +86-010-67817730; +86-010-67876255, E-mail: jinhongtao@imm.ac.cn; gengxch@nifdc.org.cn
  • Supported by:
    National Special Project Funds (Grant No. 2012ZX09302, 2013ZX09302).

Abstract:

Good laboratory practice (GLP) plays an important role in pre-clinical studies, which are a key stage in new drug research and development (R&D). The development of GLP in China started in the late 1990s. Following 20 years of developments, GLP system has already been established in this country. This review firstly evaluated all the institutions in this field, and described the annual number and total number of institutions, the distribution of GLP institutions, the types of GLP institutions, and the service provided by these GLP institutions. Since the initiation of the National Key Technology R&D Program during the 11th Five-Year Plan, it had a significant effect on the development of GLP. Therefore, the institutions which have undertaken projects from this program will be introduced later. We also described the infrastructure of hardware and software in GLP institutions along with their faults, such as variation in development and the lack of innovation.

Key words: GLP, National Key Technology R&D Program, China

CLC Number: 

Supporting: